Bruno Fuchs
Overview
Explore the profile of Bruno Fuchs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
150
Citations
2394
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Schelling G, Heesen P, Tautermann B, Wepf M, Di Federico B, Frei A, et al.
Cancers (Basel)
. 2024 Jun;
16(12).
PMID: 38927915
Background: Sarcomas present a unique challenge within healthcare systems due to their rarity and complex treatment requirements. This study explores the economic impact of sarcoma surgeries across three Swiss tertiary...
12.
Uyulmaz S, Grunherz L, Giovanoli P, Fuchs B, Lindenblatt N
Ann Plast Surg
. 2024 Jun;
93(2):221-228.
PMID: 38920154
Introduction: Postoperative chronic lymphocele and lymphedema represent severe burdens for soft tissue sarcoma patients who are already physically handicapped after an extensive surgery and a long recovery time. Incidences are...
13.
Heesen P, Elyes M, Domanski J, Schelling G, Konneker S, Fuchs B
J Clin Med
. 2024 May;
13(9).
PMID: 38731210
: This study investigates the risk factors associated with postoperative complications in musculoskeletal tumor surgeries and evaluates the impact of benchmarking in enhancing surgical outcomes. : Conducted at a tertiary...
14.
Fuchs B, Bode B, Heesen P, Kopf B, Michelitsch C, Odermatt M, et al.
Swiss Med Wkly
. 2024 Apr;
154:3473.
PMID: 38579301
No abstract available.
15.
Scharer M, Heesen P, Bode-Lesniewska B, Studer G, Fuchs B
Cancers (Basel)
. 2023 Dec;
15(24).
PMID: 38136394
Benchmarking is a fundamental tool for enhancing quality within a patient-centered healthcare framework. This study presents an analysis of time-to-treatment initiation (TTI) for sarcoma patients, utilizing a database encompassing 266...
16.
Fuchs B, Studer G, Bode-Lesniewska B, Heesen P, The Swiss Sarcoma Network
J Pers Med
. 2023 Nov;
13(11).
PMID: 38003845
The landscape of sarcoma care is on the cusp of a transformative era, spurred by the convergence of digital health and artificial intelligence (AI). This perspectives article explores the multifaceted...
17.
Elyes M, Heesen P, Schelling G, Bode-Lesniewska B, Studer G, Fuchs B
Cancers (Basel)
. 2023 Oct;
15(19).
PMID: 37835586
Sarcomas, rare and with lower survival rates than common tumors, offer insights into healthcare efficiency via the analysis of the total interval of the diagnostic pathway, combining the patient interval...
18.
Alban A, Meroni M, Fuchs B, Scaglioni M
Microsurgery
. 2023 Oct;
44(1):e31125.
PMID: 37830398
Reconstruction of knee defects still represents a challenge for reconstructive surgeons. After an extensive resection, the primary aim is to reach a stable result, while maintaining a good range of...
19.
Svantesson T, van Oudenaarde K, Fuchs B, Bode B, Vogetseder A
Arch Clin Cases
. 2023 Oct;
10(3):142-145.
PMID: 37809034
Xanthogranulomatous epithelial tumor (XGET) is an extremely rare and recently described mesenchymal neoplasm characterized by a distinctive histological appearance and clinical presentation. This case report describes a unique case of...
20.
Poskevicius A, Meroni M, Fuchs B, Scaglioni M
Microsurgery
. 2023 Sep;
44(1):e31119.
PMID: 37743714
Background: Soft tissue sarcomas are a subtle category of tumors that often require an extensive surgical resection for definitive treatment. This kind of intervention inevitably leads to large tissue damage...